Intervacc AB
556238-1748ActiveDeveloping next-generation recombinant protein vaccines for animal health.
Biotechnology Groupintervacc.com
Oversigt
- 5–9
- Medarbejdere
- 1–2.5mio SEK
- Omsætning
- 1984
- Grundlagt
Nøglebeslutningstagere
Jan Persson
CFO
@intervacc.com+46812XXXXXX
Patrik Hellberg
CIO
@intervacc.se+46707XXXXXX
Andrew Waller
CSO
@intervacc.com+44755XXXXXXX
Jonas Sohlman
CEO
@intervacc.com+46705XXXXXX
+9 flere kontakter i Funnelfeedr
Beskrivelse
Intervacc is a Swedish biotechnology company focused on advancing animal health. The core mission involves developing novel vaccines utilizing recombinant protein fusion technology. This modern approach aims to provide effective alternatives to conventional vaccines, minimizing severe side effects....